269 related articles for article (PubMed ID: 12054163)
1. Male sex and low physical activity are associated with reduced spine bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Tillmann V; Darlington AS; Eiser C; Bishop NJ; Davies HA
J Bone Miner Res; 2002 Jun; 17(6):1073-80. PubMed ID: 12054163
[TBL] [Abstract][Full Text] [Related]
2. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
[TBL] [Abstract][Full Text] [Related]
3. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
[TBL] [Abstract][Full Text] [Related]
4. No impact of disease and its treatment on bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Jain S; Jain S; Kapoor G; Virmani A; Bajpai R
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27671543
[TBL] [Abstract][Full Text] [Related]
5. Skeletal morbidity in childhood acute lymphoblastic leukemia.
Mandel K; Atkinson S; Barr RD; Pencharz P
J Clin Oncol; 2004 Apr; 22(7):1215-21. PubMed ID: 15051768
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood.
van der Sluis IM; van den Heuvel-Eibrink MM; Hählen K; Krenning EP; de Muinck Keizer-Schrama SM
Med Pediatr Oncol; 2000 Oct; 35(4):415-20. PubMed ID: 11025472
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Athanassiadou F; Tragiannidis A; Rousso I; Katsos G; Sidi V; Papageorgiou T; Papastergiou C; Tsituridis I; Koliouskas D
Turk J Pediatr; 2006; 48(2):101-4. PubMed ID: 16848106
[TBL] [Abstract][Full Text] [Related]
8. Severity of reduced bone mineral density and risk of fractures in long-term survivors of childhood leukemia and lymphoma undergoing guideline-recommended surveillance for bone health.
Bloomhardt HM; Sint K; Ross WL; Rotatori J; Ness K; Robinson C; Carpenter TO; Chow EJ; Kadan-Lottick NS
Cancer; 2020 Jan; 126(1):202-210. PubMed ID: 31536650
[TBL] [Abstract][Full Text] [Related]
9. Spinal and femoral bone mass accumulation during normal adolescence: comparison with female patients with sexual precocity and with hypogonadism.
Takahashi Y; Minamitani K; Kobayashi Y; Minagawa M; Yasuda T; Niimi H
J Clin Endocrinol Metab; 1996 Mar; 81(3):1248-53. PubMed ID: 8772607
[TBL] [Abstract][Full Text] [Related]
10. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
van Beek RD; de Muinck Keizer-Schrama SM; Hakvoort-Cammel FG; van der Sluis IM; Krenning EP; Pieters R; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2006 Jan; 46(1):88-93. PubMed ID: 15926166
[TBL] [Abstract][Full Text] [Related]
11. Little evidence of low bone mass in acute lymphoblastic leukemia survivors.
Muszynska-Roslan K; Panasiuk A; Latoch E; Krawczuk-Rybak M; Konstantynowicz J
J Clin Densitom; 2012; 15(1):108-15. PubMed ID: 21880524
[TBL] [Abstract][Full Text] [Related]
12. [Leptin, body composition and bone mineralization in children after treatment for Wilms tumor].
Muszyńska-Rosłan K; Krawczuk-Rybak M; Konstantynowicz J; Wołczyński S; Siedlecka E
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(1):53-8. PubMed ID: 15355740
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments.
Alikasifoglu A; Yetgin S; Cetin M; Tuncer M; Gumruk F; Gurgey A; Yordam N
Am J Hematol; 2005 Oct; 80(2):113-8. PubMed ID: 16184587
[TBL] [Abstract][Full Text] [Related]
14. Importance of adjusting dual-energy X-ray output for body size: an example from survivors of childhood acute lymphoblastic leukemia.
Aldhafiri F; Al-Nasser A; Al-Sugair A; Khanna S; Ahmed FS; Al-Mutairi H; Reilly JJ
J Pediatr Hematol Oncol; 2013 Jan; 35(1):e27-9. PubMed ID: 23018566
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of bone mineral density at different phases of therapy of childhood all.
Maniadaki I; Stiakaki E; Germanakis I; Kalmanti M
Pediatr Hematol Oncol; 2006; 23(1):11-8. PubMed ID: 16326407
[TBL] [Abstract][Full Text] [Related]
16. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia.
van der Sluis IM; van den Heuvel-Eibrink MM; Hählen K; Krenning EP; de Muinck Keizer-Schrama SM
J Pediatr; 2002 Aug; 141(2):204-10. PubMed ID: 12183715
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral assessment with tibial ultrasonometry and dual-energy X-ray absorptiometry in long-term survivors of acute lymphoblastic leukemia in childhood.
Lequin MH; van der Shuis IM; Van Rijn RR; Hop WC; van ven Huevel-Eibrink MM; MuinckKeizer-Schrama SM; van Kuijk C
J Clin Densitom; 2002; 5(2):167-73. PubMed ID: 12110760
[TBL] [Abstract][Full Text] [Related]
18. Bone mineral density in childhood survivors of acute lymphoblastic leukemia treated without cranial irradiation.
Brennan BM; Mughal Z; Roberts SA; Ward K; Shalet SM; Eden TO; Will AM; Stevens RF; Adams JE
J Clin Endocrinol Metab; 2005 Feb; 90(2):689-94. PubMed ID: 15562013
[TBL] [Abstract][Full Text] [Related]
19. [Bone mineral density and markers of bone turnover in patients treated for malignant disease in childhood].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M; Łuczyński W; Kaczmarski M; Wołczynski S; Piotrowska-Jastrzebska J
Med Wieku Rozwoj; 2004; 8(4 Pt 2):1041-54. PubMed ID: 15951599
[TBL] [Abstract][Full Text] [Related]
20. Bone mass after treatment for acute lymphoblastic leukemia in childhood.
Nysom K; Holm K; Michaelsen KF; Hertz H; Müller J; Mølgaard C
J Clin Oncol; 1998 Dec; 16(12):3752-60. PubMed ID: 9850018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
